# Granules India Limited, Sangareddy District, India – FDA Inspections

Source: https://www.keypedia.com/companies/granules-india-limited/eee4b9ba-83d6-4bb9-8d78-bca1e808ad45

> Inspection records and compliance data for Granules India Limited in Sangareddy District. 4 FDA inspections on record, 2 Form 483s, last inspected June 20, 2025.

---

## Details

- Name: Granules India Limited
- FEI Number: 3003723146
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, PACK, REPACK
- Address Line 1: H. No.: 6-5 & 6-11, Temple Road, Bonthapally Village, Gummadidala Mandal
- City: Sangareddy District
- Country Name: India
- Address: H. No.: 6-5 & 6-11, Temple Road, Bonthapally Village, Gummadidala Mandal, Sangareddy District, India
- Country: India

## Related Documents

- [483 - Granules India Limited - 2025-06-20](https://www.keypedia.com/records/483/granules-india-limited/20298bd3-98c2-4aa3-8184-529439bfb3c0) — source: FDA, date: June 20, 2025
- [FDA Inspection 1275217 - Granules India Limited - 2025-06-20](https://www.keypedia.com/records/fda_inspections/granules-india-limited/11ef51c0-03b9-40e9-9eeb-4d24edeb5cd4) — source: FDA, date: June 20, 2025
- FDA Inspection 1275217 - Granules India Limited - 2025-06-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 20, 2025
- [FDA Inspection 1097942 - Granules India Limited - 2019-07-26](https://www.keypedia.com/records/fda_inspections/granules-india-limited/898ac753-8047-448e-bc3d-ce39040428b9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2019
- [FDA Inspection 886648 - Granules India Limited - 2014-06-13](https://www.keypedia.com/records/fda_inspections/granules-india-limited/3713a72a-bced-4239-9979-be16de205bcd) — classification: No Action Indicated (NAI), source: FDA, date: June 13, 2014
- FDA Inspection 704749 - Granules India Limited - 2010-11-22 — classification: No Action Indicated (NAI), source: FDA, date: November 22, 2010

## Related Companies

- [SMS Pharmaceuticals Limited](https://www.keypedia.com/companies/sms-pharmaceuticals-limited/e291cac6-1ec4-4f91-a391-b1dca70f98ab)
- [USV Private Limited](https://www.keypedia.com/companies/usv-private-limited/9b38c887-cd13-4401-9fd6-4cec1f931283)
- [EuroAPI Italy SRL](https://www.keypedia.com/companies/euroapi-italy-srl/4d4fc7c3-0d32-44a1-8fdc-de90d22826dd)
- [Jiangsu Hansoh Pharmaceutical Group Co., Ltd.](https://www.keypedia.com/companies/jiangsu-hansoh-pharmaceutical-group-co-ltd/300d3bc8-8bd8-4257-b12f-4cce9a6c1f28)
- [Merck & Cie](https://www.keypedia.com/companies/merck-cie/7a318238-e1c9-4962-94fe-53359569a739)
- [Emcure Pharmaceuticals Limited](https://www.keypedia.com/companies/emcure-pharmaceuticals-limited/fd592e66-77b8-43a7-ad83-4f4001d84588)
- [Qilu Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/qilu-pharmaceutical-co-ltd/8313b57b-176c-41ab-89cc-e3dadfd3a0fc)
- [SMS Lifesciences India Limited](https://www.keypedia.com/companies/sms-lifesciences-india-limited/15b7f08f-5def-4a9b-a74c-6dda7a382c64)
- [Merck Life Science Technologies (Nantong) Co., Ltd.](https://www.keypedia.com/companies/merck-life-science-technologies-nantong-co-ltd/37493d9d-656d-4dc2-ab62-650cd0281a8d)
- [Reactimex S.A. de C.V.](https://www.keypedia.com/companies/reactimex-sa-de-cv/64312e9e-1f0b-42f7-bc6e-ac95307cf1c9)

## Related Officers

- [Investigator](https://www.keypedia.com/people/karen-a-briggs/3e77d364-25ea-48c7-87f4-36f3e170bfb5)
- [Investigator](https://www.keypedia.com/people/karishma-g-gopaul/ec5be791-b76c-4a31-bbed-9395e576d2c3)
